Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Blood tests and the adoption of AI in cognitive decline screenings have opened the door to new avenues for testing cognitive ...
Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...
A study reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta -- a hallmark of Alzheimer's disease. The findings suggest that vascular ...
Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...
More than 6 million Americans are diagnosed with Alzheimer's disease, a number expected to climb as the population ages.
The study underscores the transformative potential of AI in Alzheimer’s diagnostics. ChatGPT’s ability to analyze EHRs, MRI scans, and cognitive assessments could aid early detection, allowing for ...
Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...
There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...